Can Pfizer’s weight loss drug be as effective as Ozempic? Read the New Study
According to a peer-reviewed analysis of phase 2 clinical trial data released Monday, an oral medication produced by Pfizer medicine induces a comparable level of weight reduction as rival Novo Nordisk’s popular injection Ozempic. Late last year, the findings were presented at a medical conference; no comparisons were made between Ozempic or other weight-loss drugs and Pfizer medicine . It took JAMA Network some time to publish a peer-reviewed study. The Pfizer Experiment In a Pfizer medicine experiment, 411 persons with Type 2 diabetes were given either a placebo or the company’s medication, danuglipron, twice daily. The study discovered that after patients took either the 120-milligram or 80-milligram forms of danuglipron for 16 weeks, their body weight was “statistically significantly reduced.” Over that time, patients who took a 120-milligram version dropped, on average, about 10 pounds. As an alternative to regular injections, Pfizer medicine may have a benefit. Although the...